Bud APAC (01876) has released its results for the first nine months of 2026, recording revenue of US$4.62 billion for the period, down 3.7% year-on-year, while profit attributable to equity holders of Bud APAC fell 4.88% year-on-year to US$565 million, with normalized basic earnings per share of 4.75 US cents.
During the first nine months of 2026, total sales volume declined 4.9%, revenue dropped 3.7%, while revenue per hectoliter rose 1.2%. The group's normalized EBITDA decreased 13.2%, and the normalized EBITDA margin fell 297 basis points.
In the third quarter of 2026, total sales volume dropped 10.1%, dragged down by performance in China but partially offset by growth in India. Revenue fell 8.4%, while revenue per hectoliter increased 1.9%, benefiting from a positive country mix. The group's normalized EBITDA declined 22.9%, affected by revenue performance in China, rising costs, operating deleverage, and a decrease in other operating income.
Comments